May 15, 2025 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, has announced that data from 23 company-sponsored and funded studies, including three late-breaking presentations, will be presented at EuroPCR 2025, May 20-23 in Paris. These studies will feature data from Shockwave’s cardiovascular portfolio, including its market-leading Shockwave Intravascular Lithotripsy (IVL) platform and innovative Reducer technology that are transforming the treatment of cardiovascular disease.1

May 14, 2025 — BrightHeart, a provider of artificial intelligence (AI) solutions for pediatric cardiology and obstetrics, recently announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its second device, B-Right Views.

May 8, 2025 — Nancy Brown, chief executive officer of the American Heart Association, has been named to TIME’s 2025 TIME100 Health, a list recognizing the 100 most influential individuals in health. The full list and related tributes appear in the May 26, 2025 issue of TIME, available on newsstands on May 16, and now at time.com/time100health. 

May 12, 2025 — GE HealthCare recently unveiled Signa Sprint, an FDA 510(k) pending

May 5, 2025 — The TCT Geoffrey O. Hartzler Master Operator Award will be presented to Kenneth Rosenfield, MD, MSc, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place Oct. 25-28, 2025, in San Francisco, California. The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and leadership.

May 3, 2025 — The Society for Cardiovascular Angiography & Interventions (SCAI) announced its new leadership for 2025–26, with Srihari S. Naidu, MD, MSCAI, assuming the role of president during SCAI Scientific Sessions 2025, held May 1–3 in Washington, D.C.

The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician-scientist and pioneer in cardiovascular genetics, has been selected as the recipient of the 2025 Paul Dudley White Award.

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz 3D CTA, a new solution that automatically converts computed tomography angiography (CTA) scans into high-resolution, AI-enhanced 3D images for faster and clearer neurovascular visualization.

May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with transcatheter aortic valve replacement (TAVR) compared to other age groups, especially in regards to stroke risk, and in regards to the composite of death, stroke, and heart failure hospitalization. The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now